Kaori Davis

Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium-225-labeled HER2/neu Targeting Antibody.

C. Brayton, G. Sgouros, R. Hobbs, 2023, International journal of radiation oncology, biology, physics.